Lebwohl, Mark, Richard B. Warren, Shinichi Imafuku, Jerry Bagel, April W. Armstrong, Thierry Passeron, Subhashis Banerjee, Matthew J. Colombo, Thomas Scharnitz, Kim Hoyt, Diamant Thaci, and Andrew Blauvelt. 2024. “Deucravacitinib Long-Term Efficacy Through 4 Years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program”. SKIN The Journal of Cutaneous Medicine 8 (4):s408. https://doi.org/10.25251/skin.8.supp.408.